# Diabetic Foot: Charcot Neuroarthropathy and Limb Salvage

## Introduction

The diabetic foot represents one of the most complex problems in orthopedic and reconstructive surgery. Diabetic peripheral neuropathy, peripheral vascular disease, and impaired immune function create a triad that predisposes to ulceration, infection, and skeletal destruction. Charcot neuroarthropathy (CN) is a particularly devastating condition in which progressive bone and joint destruction leads to deformity, instability, and limb-threatening complications if not recognized and managed appropriately.

## Epidemiology

Diabetes mellitus affects over **37 million Americans**, and approximately 50% develop peripheral neuropathy. Diabetic foot ulcers affect 15-25% of diabetic patients during their lifetime. Charcot neuroarthropathy affects approximately 0.1-7.5% of diabetic patients with neuropathy. Diabetic foot complications are the leading cause of nontraumatic lower extremity amputation, and the 5-year mortality rate after a major amputation in diabetic patients exceeds 50%.

## Pathophysiology of Charcot Neuroarthropathy

### Neurotraumatic Theory

Loss of protective sensation leads to repetitive unrecognized microtrauma. Continued weight-bearing on damaged joints causes progressive destruction.

### Neurovascular Theory

Autonomic neuropathy causes increased blood flow (arteriovenous shunting) to the foot. This hyperemia results in osteoclast activation and osteopenia, weakening the bone. The combination of weakened bone and absent protective sensation leads to fracture and joint destruction.

### Inflammatory Cascade

Acute Charcot triggers a local inflammatory response with upregulation of **RANKL** and **NF-kB**, promoting osteoclast-mediated bone resorption. TNF-alpha and IL-1 are elevated, driving a destructive cytokine cascade. This inflammatory process is self-perpetuating if mechanical loading continues.

## Classification

### Eichenholtz Classification (Stages of CN)

| Stage | Name | Clinical Findings | Radiographic Findings | Management |
|-------|------|-------------------|----------------------|------------|
| 0 | Prodromal | Warmth, swelling, erythema | Normal radiographs; MRI shows marrow edema | Immediate offloading (TCC) |
| 1 | Development/Fragmentation | Continued warmth, swelling | Joint dislocation, fractures, debris | Total contact cast; non-weight-bearing |
| 2 | Coalescence | Decreased inflammation | Absorption of debris, sclerosis, early fusion | Continued offloading; transition to brace |
| 3 | Reconstruction/Consolidation | No warmth; stable foot | Remodeling, consolidation, fixed deformity | Custom-molded shoe; accommodative insoles |

**Stage 0 (Prodromal)** presents with warmth, swelling, and erythema without radiographic changes and is often misdiagnosed as infection or DVT. **Stage 1 (Development/Fragmentation)** shows joint dislocation, fractures, and debris, with radiographs demonstrating destruction and fragmentation. **Stage 2 (Coalescence)** involves decreased inflammation with absorption of debris, early healing, sclerosis, and fusion of fragments. **Stage 3 (Reconstruction/Consolidation)** shows remodeling and consolidation with fixed deformity and a stable but often misshapen foot.

### Anatomic Classification (Brodsky/Sanders and Frykberg)

| Type | Location | Frequency | Key Considerations |
|------|----------|-----------|-------------------|
| I | Midfoot (tarsometatarsal joints) | 60% (most common) | Rocker-bottom deformity; plantar ulceration |
| II | Chopart joints (talonavicular, calcaneocuboid) | ~25% | Lateral/medial instability |
| III | Ankle and subtalar joints | Least common | Most difficult to treat; often requires TTC arthrodesis |
| IV | Calcaneus (tuberosity fracture) | Rare | Posterior heel ulceration |
| V | Forefoot | Rare | Toe deformities; pressure ulcers |

**Type I (midfoot)** involves tarsometatarsal joints and is the most common location at 60%. **Type II** involves the Chopart joints (talonavicular, calcaneocuboid). **Type III** involves the ankle and subtalar joints, is least common, but is the most difficult to treat. **Type IV** involves the calcaneus (tuberosity fracture). **Type V** involves the forefoot.

![Lateral weight-bearing radiograph showing midfoot Charcot neuroarthropathy with rocker-bottom deformity](/images/orthopedic-surgery/charcot-foot-radiograph.jpg)

## Clinical Presentation and Diagnosis

### Acute Charcot

Acute Charcot presents as a **red, hot, swollen foot** in a patient with neuropathy, often without significant pain. It is frequently misdiagnosed as cellulitis, DVT, or gout. Skin temperature is typically 2 degrees Celsius or more warmer than the contralateral foot. The key differentiating feature from infection is that elevation of the limb reduces swelling and erythema in CN but not in infection.

### Imaging

Weight-bearing radiographs are the initial study and may show fractures, subluxation, fragmentation, or only subtle changes in Stage 0. MRI is highly sensitive for early (Stage 0) CN, showing bone marrow edema and joint effusion. Nuclear medicine labeled WBC scans may help differentiate CN from osteomyelitis when clinical differentiation is difficult. PET-CT is an emerging modality for distinguishing infection from CN.

### Distinguishing Charcot from Osteomyelitis

This represents one of the most challenging diagnostic dilemmas in diabetic foot care. Both may show bone marrow edema on MRI; osteomyelitis typically underlies a contiguous ulcer with a positive probe-to-bone test. Biopsy with culture and histopathology remains the gold standard when diagnosis is uncertain.

## Nonoperative Management

### Acute Charcot (Stages 0-1)

Immediate offloading is the cornerstone of treatment. A **total contact cast (TCC)** or removable boot (irremovable walker) provides non-weight-bearing or protected weight-bearing. Cast changes occur every 1-2 weeks initially, then every 2-4 weeks as swelling decreases. Offloading continues until clinical and radiographic quiescence (no warmth, no swelling, stable radiographs), typically 3-6 months. Patients then transition to a custom-molded shoe with accommodative insoles and a rigid rocker-bottom sole.

### Adjunctive Medical Therapy

Glycemic control should be optimized (target HbA1c below 7%). Bisphosphonates and calcitonin have been studied but evidence remains inconclusive. Vitamin D deficiency and metabolic bone disease should be corrected, and vascular disease addressed with appropriate referrals.

## Surgical Management

### Indications

Surgical indications include unstable deformity that cannot be braced, recurrent ulceration under a bony prominence despite appropriate offloading, infection requiring debridement or drainage, and ankle and hindfoot CN (often not amenable to bracing alone).

### Exostectomy

Exostectomy removes the plantar bony prominence causing ulceration without correcting overall alignment. It is appropriate for stable, consolidated (Stage 3) deformities with isolated plantar pressure points. This simple procedure uses a direct plantar or medial approach and must be combined with appropriate offloading footwear postoperatively.

### Realignment Arthrodesis

Realignment arthrodesis is the definitive reconstruction for unstable midfoot or hindfoot Charcot deformity. The goals are to create a stable, plantigrade, braceable foot. Techniques include midfoot beaming (axial intramedullary screws through the medial and lateral columns), plate fixation, and ring fixation. The **superconstruct** principle guides fixation: use fixation that extends beyond the zone of injury, utilize the strongest available bone (calcaneus, talus), employ the largest implants the anatomy allows, and apply devices on the tension side of the deformity.

### Tibiotalocalcaneal (TTC) Arthrodesis

TTC arthrodesis is required for ankle and hindfoot CN. The retrograde intramedullary nail is the most commonly used construct, often combined with bulk allograft or metal augments for bone loss. External fixation (Ilizarov or Taylor Spatial Frame) is an alternative, especially in the setting of active infection.

![Postoperative anteroposterior and lateral radiographs showing midfoot beaming with intramedullary screws for Charcot reconstruction](/images/orthopedic-surgery/charcot-reconstruction.jpg)

## Limb Salvage vs. Amputation

The decision involves a multidisciplinary team: orthopedic surgery, vascular surgery, infectious disease, endocrinology, wound care, and prosthetics. **Limb salvage** is preferred when adequate vascular supply is present or can be restored (ABI greater than 0.5, toe pressures greater than 30 mmHg, or successful revascularization), infection is controllable, the patient is medically fit for reconstruction, and a functional, plantigrade foot can be achieved. **Amputation** is considered when unreconstructable vascular disease leads to critical limb ischemia, uncontrolled sepsis threatens life, the foot cannot be made functional despite reconstruction, or the patient's overall medical condition precludes multiple reconstructive procedures.

![Clinical photograph of a plantigrade foot achieved after Charcot midfoot reconstruction with custom molded shoe](/images/orthopedic-surgery/charcot-reconstructed-foot.jpg)

## Key Clinical Pearls

A red, hot, swollen, insensate foot in a diabetic patient is Charcot neuroarthropathy until proven otherwise; early offloading with a total contact cast can prevent devastating deformity. Differentiating acute Charcot from osteomyelitis is one of the most difficult clinical challenges; the probe-to-bone test, labeled WBC scan, and biopsy are the most helpful adjuncts. The superconstruct principle guides fixation in Charcot reconstruction: extend fixation beyond the zone of injury, use the strongest bone available, and apply the largest implants the anatomy permits. A multidisciplinary approach is essential; glycemic control, vascular assessment, and offloading are as important as any surgical intervention.

## References

1. Rogers LC, Frykberg RG, Armstrong DG, et al. The Charcot foot in diabetes. *Diabetes Care*. 2011;34(9):2123-2129.
2. Sammarco VJ. Superconstructs in the treatment of Charcot foot deformity: plantar plating, locked plating, and axial screw fixation. *Foot Ankle Clin*. 2009;14(3):393-407.
3. Pinzur MS, Gil J, Belmares J. Treatment of osteomyelitis in Charcot foot with single-stage resection of infection, correction of deformity, and maintenance with ring fixation. *Foot Ankle Int*. 2012;33(12):1069-1074.
4. Wukich DK, Sung W. Charcot arthropathy of the foot and ankle: modern concepts and management review. *J Diabetes Complications*. 2009;23(6):409-426.